DELIVER Results - Scott D. Solomon, MD
Case description
Investigator Scott D. Solomon, MD recaps the results of the DELIVER trial, which found that among individuals with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death.
This user also sharing
Glaucoma Diagnostics: 2020 and Beyond
views: 316
Radial Nerve Ultrasound
views: 190
Hemorrhagic Stroke Case Studies
views: 354
Recommended
Severe Tricuspid Stenosis
Mohammed Zidan
views: 116
Echocardiogram: What They Show
Mohammed Zidan
views: 250
Are you Health Professional?
Register now, join the community for free access.
GET ALL THE BENEFITS THAT MEDTUBE PLATFORM OFFERS:
- Unlimited access to the largest e-library of professional videos, images, documents, courses
- Connect with peers 320,000+ Healthcare Professionals from 180 countries
- Upload and share your own cases, ask questions and discuss
- Create your professional profile and build personal recognition worldwide
- Stay up-to-date with innovative techniques, treatments, guidelines, discoveries in your fields of interest; be notified
- You are informed about innovative treatments, techniques and innovations in medicine
